Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daria Hazuda

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|April 13, 2007
Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitorsPaola Pace, M Emilia Di Francesco, Cristina Gardelli, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activityJeffrey J Hale, Richard J Budhu, Sander G Mills, et al.
Journal of Medicinal Chemistry|October 13, 2006
Macrocyclic inhibitors of beta-secretase: functional activity in an animal modelShawn J Stachel, Craig A Coburn, Sethu Sankaranarayanan, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2006
BACE-1 inhibition by a series of psi[CH2NH] reduced amide isosteresCraig A Coburn, Shawn J Stachel, Kristen G Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butaneShrenik K Shah, Natalie Chen, Ravindra N Guthikonda, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptorK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic propertiesDooseop Kim, Liping Wang, Jeffrey J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidinesChristopher L Lynch, Amy L Gentry, Jeffrey J Hale, et al.
Journal of Medicinal Chemistry|September 11, 2007
Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidonesCristina Gardelli, Emanuela Nizi, Ester Muraglia, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|April 13, 2007
Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitorsPaola Pace, M Emilia Di Francesco, Cristina Gardelli, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activityJeffrey J Hale, Richard J Budhu, Sander G Mills, et al.
Journal of Medicinal Chemistry|October 13, 2006
Macrocyclic inhibitors of beta-secretase: functional activity in an animal modelShawn J Stachel, Craig A Coburn, Sethu Sankaranarayanan, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2006
BACE-1 inhibition by a series of psi[CH2NH] reduced amide isosteresCraig A Coburn, Shawn J Stachel, Kristen G Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butaneShrenik K Shah, Natalie Chen, Ravindra N Guthikonda, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptorK Shankaran, Karla L Donnelly, Shrenik K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chainsDong-Ming Shen, Min Shu, Sander G Mills, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic propertiesDooseop Kim, Liping Wang, Jeffrey J Hale, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidinesChristopher L Lynch, Amy L Gentry, Jeffrey J Hale, et al.
Journal of Medicinal Chemistry|September 11, 2007
Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidonesCristina Gardelli, Emanuela Nizi, Ester Muraglia, et al.
Pageof 6